Stereotactic body radiation therapy (SBRT) is well suited for the palliative treatment of metastases in the brain, liver, lungs and sometimes also in the bones. In the treatment of metastases, the patient may be given 1 to 5 hypofractionated high-dose radiotherapy doses depending on the size, location and previous treatment of the metastases.
Hypofractionated stereotactic radiotherapy effectively destroys local metastases. Radiotherapy is often given for metastases after chemotherapy to stabilise the disease. In this way, the disease can be controlled without further chemotherapy.
Oncologists in Finland have long been using hypofractionated stereotactic radiotherapy with great success.
SBRT is used for the treatment of urological and gynaecological cancers, lung, intestinal, liver and breast cancer, and for the treatment of metastases of other cancers. In certain cases, SBRT can also be used as primary treatment for cancer.